Mode
Text Size
Log in / Sign up

Oncology

1416 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
VaIN recurrence rates reach up to 80% within 2-5 years following hysterectomy for cervical cancer
Oncology Sys. Review
VaIN recurrence rates reach up to 80% within 2-5 years following hysterectomy for cervical cancer High recurrence rates for vaginal precancerous lesions after hysterectomy
This systematic review examines the epidemiology, risk factors, and management of vaginal intraepithelial neoplasia (VaIN) in patients post-…
Women who have had a hysterectomy for cervical cancer face high recurrence rates of vaginal precancerous lesions within five years.
Metabolic syndrome is associated with an increased risk of oral cancer (HR: 1.12)
Oncology Meta-analysis
Metabolic syndrome is associated with an increased risk of oral cancer (HR: 1.12) Metabolic Syndrome Linked to Higher Risk of Oral Cancer
This meta-analysis of observational cohort studies involving over 6 million participants found that metabolic syndrome is associated with a …
A large-scale analysis suggests that metabolic syndrome is linked to an increased risk of developing oral cancer in adults.
High NLRP-3 Expression Linked to Poor Survival in Solid Cancers
Oncology Meta-analysis
High NLRP-3 Expression Linked to Poor Survival in Solid Cancers High NLRP-3 levels linked to worse outcomes in solid cancers
Meta-analysis shows high NLRP-3 expression predicts worse overall and disease-free survival in solid tumors, with HR 2.12 for OS.
Higher levels of the NLRP-3 protein are linked to shorter survival times and more advanced disease in several types of solid tumors.
Integrated Prognostic Criteria Improve Survival Stratification in Metastatic Castration-Sensitive Prostate Cancer
Oncology RCT
Integrated Prognostic Criteria Improve Survival Stratification in Metastatic Castration-Sensitive Prostate Cancer Trial shows improved prediction of survival in prostate cancer
Combining CHAARTED and LATITUDE criteria enhances prognostic accuracy for mCSPC, though specific treatment benefits in certain subgroups rem…
A new way to combine two scoring systems helps doctors better predict how patients with advanced prostate cancer will respond to treatment.
Sunvozertinib improves progression-free survival in patients with advanced NSCLC and EGFR exon 20 mutations
Oncology RCT
Sunvozertinib improves progression-free survival in patients with advanced NSCLC and EGFR exon 20 mutations New drug shows promise for specific type of lung cancer
This trial compared sunvozertinib against carboplatin and pemetrexed in patients with advanced nonsquamous NSCLC featuring EGFR exon 20 inse…
A new drug called sunvozertinib may help patients with a specific lung cancer mutation live longer without their tumors growing.
Early activity improves recovery and reduces complications in postoperative patients with lung cancer
Oncology Meta-analysis
Early activity improves recovery and reduces complications in postoperative patients with lung cancer Early activity helps lung cancer patients recover faster after surgery
This meta-analysis of 2,234 patients evaluates early activity for post-surgical lung cancer recovery. The analysis indicates that early acti…
Patients with lung cancer can see shorter hospital stays and fewer complications by starting early physical activity after their surgery.
Elevated inflammation-immunity-nutrition score linked to 2.13-fold higher mortality risk in cancer
Oncology Meta-analysis
Elevated inflammation-immunity-nutrition score linked to 2.13-fold higher mortality risk in cancer High Inflammation and Nutrition Scores Linked to Poorer Cancer Survival
This meta-analysis of 11 cohorts with 3,950 participants found that an elevated inflammation-immunity-nutrition score (IINS) was significant…
A high inflammation and nutrition score may indicate a poorer outlook for some cancer patients, potentially helping doctors predict outcomes…
14-3-3 proteins function as potential but unvalidated biomarkers and therapeutic targets in colorectal cancer
Oncology Sys. Review
14-3-3 proteins function as potential but unvalidated biomarkers and therapeutic targets in colorectal cancer New research identifies potential protein markers for colorectal cancer
This narrative review explores the roles of 14-3-3/YWHA proteins, including YWHAG, YWHAE, YWHAZ, YWHAB, YWHAH, and SFN, in colorectal cancer…
Researchers have identified specific 14-3-3 proteins that may play key roles in how colorectal cancer grows and spreads.
Social and cultural barriers lead to delayed diagnosis and lower screening for immigrant women with breast cancer
Oncology Sys. Review
Social and cultural barriers lead to delayed diagnosis and lower screening for immigrant women with breast cancer Cultural and language barriers create breast cancer disparities for immigrants
This narrative review examines how social, cultural, and healthcare system factors impact the experience of breast cancer among immigrant wo…
Immigrant women in Europe face significant hurdles like language barriers and cultural differences that delay breast cancer diagnosis and tr…
Orexin receptor antagonists improve sleep continuity by blocking orexin-mediated arousal signaling pathways
Oncology Sys. Review
Orexin receptor antagonists improve sleep continuity by blocking orexin-mediated arousal signaling pathways New drugs target the brain's wake signals to treat insomnia
This narrative review explores the mechanism and physiological effects of orexin receptor antagonists in treating insomnia. The authors conc…
A new class of medications works by blocking the chemicals that keep your body awake, offering a different way to manage sleep disorders.
PDAC risk prediction models for new-onset diabetes patients show a pooled C-index of 0.78
Oncology Meta-analysis
PDAC risk prediction models for new-onset diabetes patients show a pooled C-index of 0.78 New Models Predict Pancreatic Cancer Risk in New-Onset Diabetes
This meta-analysis of 14 studies involving 17 prediction models evaluated PDAC risk in patients with new-onset diabetes. The analysis found …
Researchers identified prediction models that can help identify the risk of pancreatic cancer in patients recently diagnosed with new-onset …
Combined lung cancer resection and LVRS shows 7.3% mortality estimate with significant FEV1 improvement
Oncology Meta-analysis
Combined lung cancer resection and LVRS shows 7.3% mortality estimate with significant FEV1 improvement Combined lung surgery for cancer and emphysema shows mixed results
This meta-analysis of 113 participants evaluates combined lung cancer resection and lung volume reduction surgery (LVRS) for patients with s…
A combined surgical approach for patients with both lung cancer and emphysema may improve breathing but carries significant risks.